JESSICA GRABOWSKI: Open Payments
NPI 1932217387 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 36 payments from 16 companies in 2025. Trend: 2023 $1,068 · 2024 $893 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $212 |
| GENZYME CORPORATION | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Janssen Biotech, Inc. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Galderma Laboratories, L.P. | 3 | $54 |
| LEO Pharma Inc. | 2 | $54 |
| Organon LLC | 1 | $34 |
| Incyte Corporation | 1 | $29 |
| PFIZER INC. | 1 | $28 |
Products named: DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, COSENTYX, Sotyktu, ADBRY, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
